235 related articles for article (PubMed ID: 17609426)
1. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.
Jenner MW; Leone PE; Walker BA; Ross FM; Johnson DC; Gonzalez D; Chiecchio L; Dachs Cabanas E; Dagrada GP; Nightingale M; Protheroe RK; Stockley D; Else M; Dickens NJ; Cross NC; Davies FE; Morgan GJ
Blood; 2007 Nov; 110(9):3291-300. PubMed ID: 17609426
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma.
Yang Z; Lan H; Chen X; Li P; Li S; Mo W; Tang A
Neoplasma; 2014; 61(2):170-6. PubMed ID: 24299313
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
Leonard N; Chaggar R; Jones C; Takahashi M; Nikitopoulou A; Lakhani SR
J Clin Pathol; 2001 Sep; 54(9):689-92. PubMed ID: 11533075
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of WWOX in the development of esophageal squamous cell carcinoma.
Guo W; Wang G; Dong Y; Guo Y; Kuang G; Dong Z
Mol Carcinog; 2013 Apr; 52(4):265-74. PubMed ID: 22213016
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
[TBL] [Abstract][Full Text] [Related]
6. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.
Park SW; Ludes-Meyers J; Zimonjic DB; Durkin ME; Popescu NC; Aldaz CM
Br J Cancer; 2004 Aug; 91(4):753-9. PubMed ID: 15266310
[TBL] [Abstract][Full Text] [Related]
7. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
[TBL] [Abstract][Full Text] [Related]
8. WWOX, a chromosomal fragile site gene and its role in cancer.
Ramos D; Aldaz CM
Adv Exp Med Biol; 2006; 587():149-59. PubMed ID: 17163164
[TBL] [Abstract][Full Text] [Related]
9. Loss of WWOX expression in human extrahepatic cholangiocarcinoma.
Wang M; Gu J; Wang Y; Gong B
J Cancer Res Clin Oncol; 2009 Jan; 135(1):39-44. PubMed ID: 18629536
[TBL] [Abstract][Full Text] [Related]
10. WWOX, a new potential tumor suppressor gene.
Hezova R; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):11-5. PubMed ID: 17690733
[TBL] [Abstract][Full Text] [Related]
11. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
[TBL] [Abstract][Full Text] [Related]
12. The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.
Aderca I; Moser CD; Veerasamy M; Bani-Hani AH; Bonilla-Guerrero R; Ahmed K; Shire A; Cazanave SC; Montoya DP; Mettler TA; Burgart LJ; Nagorney DM; Thibodeau SN; Cunningham JM; Lai JP; Roberts LR
J Hepatol; 2008 Sep; 49(3):373-83. PubMed ID: 18620777
[TBL] [Abstract][Full Text] [Related]
13. WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study.
Żelazowski MJ; Płuciennik E; Pasz-Walczak G; Potemski P; Kordek R; Bednarek AK
Tumour Biol; 2011 Jun; 32(3):551-60. PubMed ID: 21347750
[TBL] [Abstract][Full Text] [Related]
14. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.
Kosla K; Pluciennik E; Kurzyk A; Jesionek-Kupnicka D; Kordek R; Potemski P; Bednarek AK
J Neurooncol; 2011 Jan; 101(2):207-13. PubMed ID: 20535528
[TBL] [Abstract][Full Text] [Related]
16. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
Lee HL; Cheng HL; Liu YF; Chou MC; Yang SF; Chou YE
PLoS One; 2017; 12(4):e0176141. PubMed ID: 28426730
[TBL] [Abstract][Full Text] [Related]
17. The WWOX gene inhibits the growth of U266 multiple myeloma cells by triggering the intrinsic apoptotic pathway.
Zhang H; Kong L; Cui Z; Du W; He Y; Yang Z; Wang L; Chen X
Int J Mol Med; 2014 Sep; 34(3):804-9. PubMed ID: 24968878
[TBL] [Abstract][Full Text] [Related]
18. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations.
Maeda N; Semba S; Nakayama S; Yanagihara K; Yokozaki H
Virchows Arch; 2010 Oct; 457(4):423-32. PubMed ID: 20737170
[TBL] [Abstract][Full Text] [Related]
19. Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease.
van Andel H; Kocemba KA; de Haan-Kramer A; Mellink CH; Piwowar M; Broijl A; van Duin M; Sonneveld P; Maurice MM; Kersten MJ; Spaargaren M; Pals ST
Oncogene; 2017 Apr; 36(15):2105-2115. PubMed ID: 27775078
[TBL] [Abstract][Full Text] [Related]
20. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.
Yeh A; Wei M; Golub SB; Yamashiro DJ; Murty VV; Tycko B
Genes Chromosomes Cancer; 2002 Oct; 35(2):156-63. PubMed ID: 12203779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
